Brevan Howard Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $590K | Buy |
50,979
+36,661
| +256% | +$425K | ﹤0.01% | 1192 |
|
|
2025
Q1 | $125K | Sell |
14,318
-363
| -2% | -$3.17K | ﹤0.01% | 990 |
|
|
2024
Q4 | $211K | Sell |
14,681
-10,929
| -43% | -$157K | ﹤0.01% | 865 |
|
|
2024
Q3 | $578K | Buy |
+25,610
| New | +$578K | ﹤0.01% | 591 |
|
|
2024
Q2 | – | Sell |
-11,012
| Closed | -$413K | – | 1352 |
|
|
2024
Q1 | $413K | Sell |
11,012
-6,639
| -38% | -$249K | ﹤0.01% | 475 |
|
|
2023
Q4 | $988K | Buy |
+17,651
| New | +$988K | 0.01% | 194 |
|